deguelin has been researched along with benzyloxycarbonylleucyl-leucyl-leucine aldehyde in 2 studies
Studies (deguelin) | Trials (deguelin) | Recent Studies (post-2010) (deguelin) | Studies (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Trials (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) | Recent Studies (post-2010) (benzyloxycarbonylleucyl-leucyl-leucine aldehyde) |
---|---|---|---|---|---|
182 | 0 | 115 | 2,473 | 3 | 1,057 |
Protein | Taxonomy | deguelin (IC50) | benzyloxycarbonylleucyl-leucyl-leucine aldehyde (IC50) |
---|---|---|---|
Proteasome subunit beta type-11 | Homo sapiens (human) | 1.9893 | |
Calpain-9 | Homo sapiens (human) | 9.88 | |
Proteasome subunit alpha type-7 | Homo sapiens (human) | 1.9893 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 3.9 | |
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 3.8999 | |
Aromatase | Homo sapiens (human) | 0.044 | |
Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.5 | |
Proteasome subunit beta type-1 | Homo sapiens (human) | 1.0853 | |
Proteasome subunit alpha type-1 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-2 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-3 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-4 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-8 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-9 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha type-5 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-4 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-6 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-5 | Homo sapiens (human) | 0.6088 | |
Proteasome subunit beta type-10 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-3 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-2 | Homo sapiens (human) | 2.0443 | |
Proteasome subunit alpha type-6 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit alpha-type 8 | Homo sapiens (human) | 1.9893 | |
Proteasome subunit beta type-7 | Homo sapiens (human) | 1.9893 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, WK; Jeong, JW; Jin, Q; Kang, HJ; Kim, KW; Lee, HY; Oh, SH; Woo, JK | 1 |
Feng, B; Mu, J; Qi, W; Tang, JY; Wei, Y; Wu, Q; Yang, LL; Zeng, W; Zhang, Q | 1 |
2 other study(ies) available for deguelin and benzyloxycarbonylleucyl-leucyl-leucine aldehyde
Article | Year |
---|---|
Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Aorta; Blotting, Western; Cell Hypoxia; Cell Movement; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Collagen; Culture Media, Conditioned; Cysteine Proteinase Inhibitors; Drug Combinations; Endothelium, Vascular; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Laminin; Leupeptins; Luciferases; Mice; Neoplasms; Neovascularization, Pathologic; Proteasome Endopeptidase Complex; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; Rotenone; Tumor Cells, Cultured; Ubiquitin; Vascular Endothelial Growth Factor A; Zebrafish | 2008 |
MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy.
Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glomerular Mesangium; Glucose; Humans; Inflammation; Inflammation Mediators; Kidney; Leupeptins; Male; Mesangial Cells; Proteasome Inhibitors; Protective Agents; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Rotenone; Signal Transduction | 2019 |